Stuart M. Levitz - Publications

Affiliations: 
Boston University, Boston, MA, United States 
Area:
Immunology, Microbiology Biology

116 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wang R, Oliveira LVN, Lourenco D, Gomez CL, Lee CK, Hester MM, Mou Z, Ostroff GR, Specht CA, Levitz SM. Immunological correlates of protection following vaccination with glucan particles containing Cryptococcus neoformans chitin deacetylases. Npj Vaccines. 8: 6. PMID 36732332 DOI: 10.1038/s41541-023-00606-0  0.316
2019 Hester MM, Lee CK, Abraham A, Khoshkenar P, Ostroff GR, Levitz SM, Specht CA. Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens. Vaccine. PMID 31699504 DOI: 10.1016/J.Vaccine.2019.10.051  0.355
2019 Khan NS, Lukason DP, Feliu M, Ward RA, Lord AK, Reedy JL, Ramirez-Ortiz ZG, Tam JM, Kasperkovitz PV, Negoro PE, Vyas TD, Xu S, Brinkmann MM, Acharaya M, Artavanis-Tsakonas K, ... ... Levitz SM, et al. CD82 controls CpG-dependent TLR9 signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201901547R. PMID 31408613 DOI: 10.1096/Fj.201901547R  0.6
2019 Abraham A, Ostroff G, Levitz SM, Oyston PCF. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens. Clinical and Experimental Immunology. PMID 31400225 DOI: 10.1111/Cei.13356  0.353
2019 Chang CC, Levitz SM. Fungal immunology in clinical practice: Magical realism or practical reality? Medical Mycology. 57: S294-S306. PMID 31292656 DOI: 10.1093/Mmy/Myy165  0.382
2019 Akilimali NA, Muema DM, Specht C, Chang CC, Moosa MS, Levitz SM, Lewin SR, French MA, Ndung'u T. Cryptococcosis-associated Immune Reconstitution Inflammatory Syndrome is associated with Dysregulation of IL-7/IL-7 Receptor Signaling Pathway in T-cells and Monocyte Activation. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30649031 DOI: 10.1097/Qai.0000000000001946  0.315
2018 Whelan AO, Flick-Smith HC, Homan J, Shen ZT, Carpenter Z, Khoshkenar P, Abraham A, Walker NJ, Levitz SM, Ostroff GR, Oyston PCF. Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles. Plos One. 13: e0200213. PMID 30296254 DOI: 10.1371/Journal.Pone.0200213  0.354
2018 Teitz-Tennenbaum S, Viglianti SP, Roussey JA, Levitz SM, Olszewski MA, Osterholzer JJ. Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 30097531 DOI: 10.4049/Jimmunol.1800070  0.373
2018 Deepe GS, Buesing WR, Ostroff GR, Abraham A, Specht CA, Huang H, Levitz SM. Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice. Vaccine. PMID 29729993 DOI: 10.1016/J.Vaccine.2018.04.047  0.355
2017 Lionakis MS, Levitz SM. Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts. Annual Review of Immunology. PMID 29237128 DOI: 10.1146/Annurev-Immunol-042617-053318  0.362
2017 Specht CA, Lee CK, Huang H, Hester MM, Liu J, Luckie BA, Torres Santana MA, Mirza Z, Khoshkenar P, Abraham A, Shen ZT, Lodge JK, Akalin A, Homan J, Ostroff GR, ... Levitz SM, et al. Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species. Mbio. 8. PMID 29184017 DOI: 10.1128/Mbio.01872-17  0.343
2017 Scriven JE, Tenforde MW, Levitz SM, Jarvis JN. Modulating host immune responses to fight invasive fungal infections. Current Opinion in Microbiology. 40: 95-103. PMID 29154044 DOI: 10.1016/J.Mib.2017.10.018  0.399
2017 Ketelut-Carneiro N, Ghosh S, Levitz SM, Fitzgerald KA, da Silva JS. A Dectin-1-caspase-8 pathway licenses canonical caspase-1 inflammasome activation and IL-1β release in response to a pathogenic fungus. The Journal of Infectious Diseases. PMID 29099934 DOI: 10.1093/Infdis/Jix568  0.321
2017 Dambuza IM, Levitz SM, Netea MG, Brown GD. Fungal Recognition and Host Defense Mechanisms. Microbiology Spectrum. 5. PMID 28752813 DOI: 10.1128/Microbiolspec.Funk-0050-2016  0.317
2016 Upadhya R, Lam WC, Maybruck B, Specht CA, Levitz SM, Lodge JK. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans. Mbio. 7. PMID 27165801 DOI: 10.1128/Mbio.00547-16  0.414
2015 Specht CA, Lee CK, Huang H, Tipper DJ, Shen ZT, Lodge JK, Leszyk J, Ostroff GR, Levitz SM. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts. Mbio. 6. PMID 26695631 DOI: 10.1128/Mbio.01905-15  0.333
2015 Panackal AA, Wuest SC, Lin YC, Wu T, Zhang N, Kosa P, Komori M, Blake A, Browne SK, Rosen LB, Hagen F, Meis J, Levitz SM, Quezado M, Hammoud D, et al. Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis. Plos Pathogens. 11: e1004884. PMID 26020932 DOI: 10.1371/Journal.Ppat.1004884  0.417
2015 Wiesner DL, Specht CA, Lee CK, Smith KD, Mukaremera L, Lee ST, Lee CG, Elias JA, Nielsen JN, Boulware DR, Bohjanen PR, Jenkins MK, Levitz SM, Nielsen K. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. Plos Pathogens. 11: e1004701. PMID 25764512 DOI: 10.1371/Journal.Ppat.1004701  0.423
2015 Loures FV, Röhm M, Lee CK, Santos E, Wang JP, Specht CA, Calich VL, Urban CF, Levitz SM. Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps. Plos Pathogens. 11: e1004643. PMID 25659141 DOI: 10.1371/Journal.Ppat.1004643  0.396
2015 Levitz SM, Huang H, Ostroff GR, Specht CA. Exploiting fungal cell wall components in vaccines. Seminars in Immunopathology. 37: 199-207. PMID 25404118 DOI: 10.1007/S00281-014-0460-6  0.402
2014 Santos E, Levitz SM. Fungal vaccines and immunotherapeutics. Cold Spring Harbor Perspectives in Medicine. 4: a019711. PMID 25368016 DOI: 10.1101/Cshperspect.A019711  0.31
2014 Ganesan S, Rathinam VA, Bossaller L, Army K, Kaiser WJ, Mocarski ES, Dillon CP, Green DR, Mayadas TN, Levitz SM, Hise AG, Silverman N, Fitzgerald KA. Caspase-8 modulates dectin-1 and complement receptor 3-driven IL-1β production in response to β-glucans and the fungal pathogen, Candida albicans. Journal of Immunology (Baltimore, Md. : 1950). 193: 2519-30. PMID 25063877 DOI: 10.4049/Jimmunol.1400276  0.336
2014 Bueter CL, Lee CK, Wang JP, Ostroff GR, Specht CA, Levitz SM. Spectrum and mechanisms of inflammasome activation by chitosan. Journal of Immunology (Baltimore, Md. : 1950). 192: 5943-51. PMID 24829412 DOI: 10.4049/Jimmunol.1301695  0.37
2014 De Jesus M, Ostroff GR, Levitz SM, Bartling TR, Mantis NJ. A population of Langerin-positive dendritic cells in murine Peyer's patches involved in sampling β-glucan microparticles. Plos One. 9: e91002. PMID 24632738 DOI: 10.1371/Journal.Pone.0091002  0.344
2013 Cole GT, Hung CY, Sanderson SD, Hurtgen BJ, Wüthrich M, Klein BS, Deepe GS, Ostroff GR, Levitz SM. Novel strategies to enhance vaccine immunity against coccidioidomycosis. Plos Pathogens. 9: e1003768. PMID 24367252 DOI: 10.1371/Journal.Ppat.1003768  0.346
2013 Quintin J, Levitz SM. NKp30 enables NK cells to act naturally with fungi. Cell Host & Microbe. 14: 369-71. PMID 24139394 DOI: 10.1016/J.Chom.2013.10.001  0.347
2013 Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM. Characterization and optimization of the glucan particle-based vaccine platform. Clinical and Vaccine Immunology : Cvi. 20: 1585-91. PMID 23945157 DOI: 10.1128/Cvi.00463-13  0.417
2013 Chang CC, Lim A, Omarjee S, Levitz SM, Gosnell BI, Spelman T, Elliott JH, Carr WH, Moosa MY, Ndung'u T, Lewin SR, French MA. Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy. The Journal of Infectious Diseases. 208: 898-906. PMID 23766525 DOI: 10.1093/Infdis/Jit271  0.367
2013 Jarvis JN, Casazza JP, Stone HH, Meintjes G, Lawn SD, Levitz SM, Harrison TS, Koup RA. The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis. The Journal of Infectious Diseases. 207: 1817-28. PMID 23493728 DOI: 10.1093/Infdis/Jit099  0.365
2012 Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Science Translational Medicine. 4: 165rv13. PMID 23253612 DOI: 10.1126/Scitranslmed.3004404  0.312
2012 Hurtgen BJ, Hung CY, Ostroff GR, Levitz SM, Cole GT. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis. Infection and Immunity. 80: 3960-74. PMID 22949556 DOI: 10.1128/Iai.00566-12  0.424
2012 Huang H, Ostroff GR, Lee CK, Agarwal S, Ram S, Rice PA, Specht CA, Levitz SM. Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans. Journal of Immunology (Baltimore, Md. : 1950). 189: 312-7. PMID 22649195 DOI: 10.4049/Jimmunol.1200603  0.422
2012 Levitz SM, Golenbock DT. Beyond empiricism: informing vaccine development through innate immunity research. Cell. 148: 1284-92. PMID 22424235 DOI: 10.1016/J.Cell.2012.02.012  0.358
2011 Cohen NR, Tatituri RV, Rivera A, Watts GF, Kim EY, Chiba A, Fuchs BB, Mylonakis E, Besra GS, Levitz SM, Brigl M, Brenner MB. Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi. Cell Host & Microbe. 10: 437-50. PMID 22100160 DOI: 10.1016/J.Chom.2011.09.011  0.439
2011 Wang JP, Lee CK, Akalin A, Finberg RW, Levitz SM. Contributions of the MyD88-dependent receptors IL-18R, IL-1R, and TLR9 to host defenses following pulmonary challenge with Cryptococcus neoformans. Plos One. 6: e26232. PMID 22039448 DOI: 10.1371/Journal.Pone.0026232  0.344
2011 Mansour MK, Vyas JM, Levitz SM. Dynamic virulence: real-time assessment of intracellular pathogenesis links Cryptococcus neoformans phenotype with clinical outcome. Mbio. 2. PMID 21954307 DOI: 10.1128/Mbio.00217-11  0.574
2011 Agarwal S, Specht CA, Haibin H, Ostroff GR, Ram S, Rice PA, Levitz SM. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans. Mbio. 2. PMID 21878570 DOI: 10.1128/Mbio.00178-11  0.315
2011 Bueter CL, Lee CK, Rathinam VA, Healy GJ, Taron CH, Specht CA, Levitz SM. Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis. The Journal of Biological Chemistry. 286: 35447-55. PMID 21862582 DOI: 10.1074/Jbc.M111.274936  0.309
2011 Ramirez-Ortiz ZG, Lee CK, Wang JP, Boon L, Specht CA, Levitz SM. A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host & Microbe. 9: 415-24. PMID 21575912 DOI: 10.1016/J.Chom.2011.04.007  0.432
2010 Jesus MD, Nicola AM, Chow SK, Lee IR, Nong S, Specht CA, Levitz SM, Casadevall A. Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence. 1: 500-8. PMID 21178496 DOI: 10.4161/Viru.1.6.13451  0.337
2010 Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. Mbio. 1. PMID 20802824 DOI: 10.1128/Mbio.00164-10  0.432
2010 Levitz SM. Innate recognition of fungal cell walls. Plos Pathogens. 6: e1000758. PMID 20421940 DOI: 10.1371/Journal.Ppat.1000758  0.366
2009 Levitz SM. Th17 cells bounce off the fungal wall. Cell Host & Microbe. 5: 311-3. PMID 19380108 DOI: 10.1016/J.Chom.2009.04.004  0.367
2009 Huang H, Ostroff GR, Lee CK, Wang JP, Specht CA, Levitz SM. Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists. Infection and Immunity. 77: 1774-81. PMID 19273561 DOI: 10.1128/Iai.00086-09  0.346
2009 Levitz SM, Shoham S, Cleary JD. Toll-like receptor 4 polymorphisms and aspergillosis. The New England Journal of Medicine. 360: 634; author reply 63. PMID 19196681 DOI: 10.1056/Nejmc082337  0.345
2009 Wozniak KL, Levitz SM. Isolation and purification of antigenic components of Cryptococcus. Methods in Molecular Biology (Clifton, N.J.). 470: 71-83. PMID 19089377 DOI: 10.1007/978-1-59745-204-5_7  0.441
2009 Levitz SM. Genetic factors associated with susceptibility to invasive aspergillosis Current Fungal Infection Reports. 3: 129-130. DOI: 10.1007/S12281-009-0026-6  0.363
2009 Levitz SM, Specht CA. Recognition of the fungal cell wall by innate immune receptors Current Fungal Infection Reports. 3: 179-185. DOI: 10.1007/S12281-009-0023-9  0.389
2008 Wozniak KL, Levitz SM. Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infection and Immunity. 76: 4764-71. PMID 18678670 DOI: 10.1128/Iai.00660-08  0.356
2008 Dan JM, Wang JP, Lee CK, Levitz SM. Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides. Plos One. 3: e2046. PMID 18446192 DOI: 10.1371/Journal.Pone.0002046  0.708
2008 Dan JM, Kelly RM, Lee CK, Levitz SM. Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infection and Immunity. 76: 2362-7. PMID 18391001 DOI: 10.1128/Iai.00095-08  0.702
2008 Ramirez-Ortiz ZG, Specht CA, Wang JP, Lee CK, Bartholomeu DC, Gazzinelli RT, Levitz SM. Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infection and Immunity. 76: 2123-9. PMID 18332208 DOI: 10.1128/Iai.00047-08  0.404
2007 Lam JS, Huang H, Levitz SM. Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells. Plos One. 2: e1009. PMID 17925857 DOI: 10.1371/Journal.Pone.0001009  0.624
2007 Specht CA, Nong S, Dan JM, Lee CK, Levitz SM. Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein. The Journal of Infectious Diseases. 196: 796-800. PMID 17674324 DOI: 10.1086/520536  0.684
2007 Luong M, Lam JS, Chen J, Levitz SM. Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. Vaccine. 25: 4340-4. PMID 17412460 DOI: 10.1016/J.Vaccine.2007.03.027  0.663
2006 Yauch LE, Lam JS, Levitz SM. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. Plos Pathogens. 2: e120. PMID 17096589 DOI: 10.1371/Journal.Ppat.0020120  0.78
2006 Dan JM, Levitz SM. Prospects for development of vaccines against fungal diseases. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 9: 105-10. PMID 16820318 DOI: 10.1016/J.Drup.2006.05.004  0.646
2006 Wozniak KL, Vyas JM, Levitz SM. In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis. Infection and Immunity. 74: 3817-24. PMID 16790753 DOI: 10.1128/Iai.00317-06  0.427
2006 Levitz SM, Specht CA. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. Fems Yeast Research. 6: 513-24. PMID 16696647 DOI: 10.1111/J.1567-1364.2006.00071.X  0.446
2006 Levitz SM, Boekhout T. Cryptococcus: the once-sleeping giant is fully awake. Fems Yeast Research. 6: 461-2. PMID 16696641 DOI: 10.1111/J.1567-1364.2006.00113.X  0.338
2006 Mansour MK, Latz E, Levitz SM. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 176: 3053-61. PMID 16493064 DOI: 10.4049/Jimmunol.176.5.3053  0.674
2005 Lam JS, Mansour MK, Specht CA, Levitz SM. A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. Journal of Immunology (Baltimore, Md. : 1950). 175: 7496-503. PMID 16301657 DOI: 10.4049/Jimmunol.175.11.7496  0.717
2005 Yauch LE, Mansour MK, Levitz SM. Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo. Infection and Immunity. 73: 8429-32. PMID 16299344 DOI: 10.1128/Iai.73.12.8429-8432.2005  0.758
2005 Banks IR, Specht CA, Donlin MJ, Gerik KJ, Levitz SM, Lodge JK. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryotic Cell. 4: 1902-12. PMID 16278457 DOI: 10.1128/Ec.4.11.1902-1912.2005  0.349
2005 Shoham S, Levitz SM. The immune response to fungal infections. British Journal of Haematology. 129: 569-82. PMID 15916679 DOI: 10.1111/J.1365-2141.2005.05397.X  0.358
2005 Kelly RM, Chen J, Yauch LE, Levitz SM. Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infection and Immunity. 73: 592-8. PMID 15618199 DOI: 10.1128/Iai.73.1.592-598.2005  0.775
2004 Levitz SM. Interactions of Toll-like receptors with fungi. Microbes and Infection / Institut Pasteur. 6: 1351-5. PMID 15596119 DOI: 10.1016/J.Micinf.2004.08.014  0.364
2004 Herrero AB, Magnelli P, Mansour MK, Levitz SM, Bussey H, Abeijon C. KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties. Eukaryotic Cell. 3: 1423-32. PMID 15590817 DOI: 10.1128/Ec.3.6.1423-1432.2004  0.575
2004 Yauch LE, Mansour MK, Shoham S, Rottman JB, Levitz SM. Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infection and Immunity. 72: 5373-82. PMID 15322035 DOI: 10.1128/Iai.72.9.5373-5382.2004  0.769
2004 Bellocchio S, Montagnoli C, Bozza S, Gaziano R, Rossi G, Mambula SS, Vecchi A, Mantovani A, Levitz SM, Romani L. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. Journal of Immunology (Baltimore, Md. : 1950). 172: 3059-69. PMID 14978111 DOI: 10.4049/Jimmunol.172.5.3059  0.376
2004 Mansour MK, Yauch LE, Rottman JB, Levitz SM. Protective efficacy of antigenic fractions in mouse models of cryptococcosis. Infection and Immunity. 72: 1746-54. PMID 14977983 DOI: 10.1128/Iai.72.3.1746-1754.2004  0.784
2003 Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. The Journal of Biological Chemistry. 278: 37561-8. PMID 12860979 DOI: 10.1074/Jbc.M306137200  0.72
2002 Huang C, Nong SH, Mansour MK, Specht CA, Levitz SM. Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses. Infection and Immunity. 70: 5485-93. PMID 12228274 DOI: 10.1128/Iai.70.10.5485-5493.2002  0.65
2002 Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. The Journal of Biological Chemistry. 277: 39320-6. PMID 12171914 DOI: 10.1074/Jbc.M201683200  0.724
2002 Mansour MK, Levitz SM. Interactions of fungi with phagocytes. Current Opinion in Microbiology. 5: 359-65. PMID 12160853 DOI: 10.1016/S1369-5274(02)00342-9  0.605
2002 Levitz SM. Receptor-mediated recognition of Cryptococcus neoformans. Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology. 43: 133-6. PMID 12145626 DOI: 10.3314/Jjmm.43.133  0.406
2002 Mansour MK, Schlesinger LS, Levitz SM. Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. Journal of Immunology (Baltimore, Md. : 1950). 168: 2872-9. PMID 11884457 DOI: 10.4049/Jimmunol.168.6.2872  0.66
2002 Levitz SM. Does amoeboid reasoning explain the evolution and maintenance of virulence factors in Cryptococcus neoformans? Proceedings of the National Academy of Sciences of the United States of America. 98: 14760-2. PMID 11752420 DOI: 10.1073/Pnas.261612398  0.357
2001 Levitz SM, Nong S, Mansour MK, Huang C, Specht CA. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proceedings of the National Academy of Sciences of the United States of America. 98: 10422-7. PMID 11504924 DOI: 10.1073/Pnas.181331398  0.652
2001 Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. Journal of Immunology (Baltimore, Md. : 1950). 166: 4620-6. PMID 11254720 DOI: 10.4049/Jimmunol.166.7.4620  0.395
2000 Ieong MH, Reardon CC, Levitz SM, Kornfeld H. Human immunodeficiency virus type 1 infection of alveolar macrophages impairs their innate fungicidal activity American Journal of Respiratory and Critical Care Medicine. 162: 966-970. PMID 10988114 DOI: 10.1164/Ajrccm.162.3.9912054  0.328
2000 Huang C, Levitz SM. Stimulation of macrophage inflammatory protein-1alpha, macrophage inflammatory protein-1beta, and RANTES by Candida albicans and Cryptococcus neoformans in peripheral blood mononuclear cells from persons with and without human immunodeficiency virus infection. The Journal of Infectious Diseases. 181: 791-4. PMID 10669379 DOI: 10.1086/315250  0.326
1999 Rongrungruang Y, Levitz SM. Interactions of Penicillium marneffei with human leukocytes in vitro. Infection and Immunity. 67: 4732-6. PMID 10456924 DOI: 10.1128/Iai.67.9.4732-4736.1999  0.375
1999 Levitz SM, Nong SH, Seetoo KF, Harrison TS, Speizer RA, Simons ER. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infection and Immunity. 67: 885-90. PMID 9916104 DOI: 10.1128/Iai.67.2.885-890.1999  0.308
1997 Levitz SM, Harrison TS, Tabuni A, Liu X. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. The Journal of Clinical Investigation. 100: 1640-6. PMID 9294133 DOI: 10.1172/Jci119688  0.329
1997 Levitz SM, North EA. Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells stimulated by Cryptococcus neoformans. Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society For Human and Animal Mycology. 35: 229-36. PMID 9292418 DOI: 10.1080/02681219780001201  0.371
1997 Harrison TS, Nong S, Levitz SM. Induction of human immunodeficiency virus type 1 expression in monocytic cells by Cryptococcus neoformans and Candida albicans. The Journal of Infectious Diseases. 176: 485-91. PMID 9237716 DOI: 10.1086/514068  0.31
1997 Levitz SM, Tabuni A, Kozel TR, MacGill RS, Ingalls RR, Golenbock DT. Binding of Cryptococcus neoformans to heterologously expressed human complement receptors Infection and Immunity. 65: 931-935. PMID 9038299 DOI: 10.1128/Iai.65.3.931-935.1997  0.318
1996 Jiang Y, Russell TR, Graves DT, Cheng H, Mong SH, Levitz SM. Monocyte chemoattractant protein 1 and interleukin-8 production in mononuclear cells stimulated by oral microorganisms Infection and Immunity. 64: 4450-4455. PMID 8890191 DOI: 10.1128/Iai.64.11.4450-4455.1996  0.339
1996 Kozel TR, Tabuni A, Young BJ, Levitz SM. Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells Infection and Immunity. 64: 2336-2338. PMID 8675346 DOI: 10.1128/Iai.64.6.2336-2338.1996  0.344
1996 Levitz SM, Tabuni A, Nong SH, Golenbock DT. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infection and Immunity. 64: 945-51. PMID 8641805 DOI: 10.1128/Iai.64.3.945-951.1996  0.31
1996 Levitz SM, North EA. gamma Interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans. Infection and Immunity. 64: 1595-9. PMID 8613366 DOI: 10.1128/Iai.64.5.1595-1599.1996  0.399
1995 Harrison TS, Kornfeld H, Levitz SM. The effect of infection with human immunodeficiency virus on the anticryptococcal activity of lymphocytes and monocytes Journal of Infectious Diseases. 172: 665-671. PMID 7658057 DOI: 10.1093/Infdis/172.3.665  0.34
1995 Levitz SM, North EA, Dupont MP, Harrison TS. Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes. Infection and Immunity. 63: 3550-4. PMID 7642290 DOI: 10.1128/Iai.63.9.3550-3554.1995  0.371
1995 Levitz SM, Mathews HL, Murphy JW. Direct antimicrobial activity of T cells. Immunology Today. 16: 387-91. PMID 7546195 DOI: 10.1016/0167-5699(95)80007-7  0.393
1994 Levitz SM, Dupont MP, Smail EH. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infection and Immunity. 62: 194-202. PMID 8262627 DOI: 10.1128/Iai.62.1.194-202.1994  0.422
1994 Levitz SM, Tabuni A, Kornfeld H, Reardon CC, Golenbock DT. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans Infection and Immunity. 62: 1975-1981. PMID 8168965 DOI: 10.1128/Iai.62.5.1975-1981.1994  0.325
1993 Roseff SA, Levitz SM. Effect of endothelial cells on phagocyte-mediated anticryptococcal activity. Infection and Immunity. 61: 3818-24. PMID 8359903 DOI: 10.1128/Iai.61.9.3818-3824.1993  0.316
1993 Duncan RA, von Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM. Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection. The New England Journal of Medicine. 328: 393-8. PMID 8093636 DOI: 10.1056/Nejm199302113280604  0.36
1993 Levitz SM, Dupont MP. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. The Journal of Clinical Investigation. 91: 1490-8. PMID 7682573 DOI: 10.1172/Jci116354  0.397
1993 Kappe R, Levitz SM, Cassone A, Washburn RG. Mechanisms of host defence against fungal infection. Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society For Human and Animal Mycology. 167-77. PMID 1474441 DOI: 10.1080/02681219280000861  0.426
1992 Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Reviews of Infectious Diseases. 13: 1163-9. PMID 1775849 DOI: 10.1093/Clinids/13.6.1163  0.315
1992 Treseler CB, Maziarz RT, Levitz SM. Biological activity of interleukin-2 bound to Candida albicans. Infection and Immunity. 60: 183-8. PMID 1729181 DOI: 10.1128/Iai.60.1.183-188.1992  0.312
1992 Levitz SM. Overview of host defenses in fungal infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S37-42. PMID 1562693 DOI: 10.1093/Clinids/14.Supplement_1.S37  0.384
1992 Levitz SM, Tabuni A, Wagner R, Kornfeld H, Smail EH. Binding of Unopsonized Cryptococcus neoformans by Human Bronchoalveolar Macrophages: Inhibition by a Large-Molecular-Size Serum Component Journal of Infectious Diseases. 166: 866-873. PMID 1527424 DOI: 10.1093/Infdis/166.4.866  0.306
1992 Wagner RP, Levitz SM, Tabuni A, Kornfeld H. HIV-1 envelope protein (gp120) inhibits the activity of human bronchoalveolar macrophages against Cryptococcus neoformans American Review of Respiratory Disease. 146: 1434-1438. PMID 1456558 DOI: 10.1164/Ajrccm/146.6.1434  0.329
1991 Levitz SM, DiBenedetto DJ, Diamond RD. Inhibition and killing of fungi by the polyamine oxidase-polyamine system. Antifungal activity of the PAO-polyamine system. Antonie Van Leeuwenhoek. 58: 107-14. PMID 2264722 DOI: 10.1007/Bf00422726  0.305
1991 Levitz SM, Farrell TP, Maziarz RT. Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture. The Journal of Infectious Diseases. 163: 1108-13. PMID 2019758 DOI: 10.1093/Infdis/163.5.1108  0.426
1991 Levitz SM. Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans. Infection and Immunity. 59: 3393-7. PMID 1894353 DOI: 10.1128/Iai.59.10.3393-3397.1991  0.337
1990 Meshulam T, Levitz SM, Diamond RD, Sugar AM. Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils. The Journal of Antimicrobial Chemotherapy. 24: 741-5. PMID 2689424 DOI: 10.1093/Jac/24.5.741  0.319
1990 Levitz SM, Farrell TP. Human neutrophil degranulation stimulated by Aspergillus fumigatus. Journal of Leukocyte Biology. 47: 170-5. PMID 2406356 DOI: 10.1002/Jlb.47.2.170  0.319
1990 Levitz SM, Farrell TP. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. Infection and Immunity. 58: 1201-9. PMID 2182538 DOI: 10.1128/Iai.58.5.1201-1209.1990  0.325
1989 Kozel TR, Wilson MA, Farrell TP, Levitz SM. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae Infection and Immunity. 57: 3412-3417. PMID 2680973 DOI: 10.1128/Iai.57.11.3412-3417.1989  0.327
1987 Levitz SM, DiBenedetto DJ, Diamond RD. A rapid fluorescent assay to distinguish attached from phagocytized yeast particles. Journal of Immunological Methods. 101: 37-42. PMID 3112238 DOI: 10.1016/0022-1759(87)90213-4  0.34
1984 Waldorf AR, Levitz SM, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. The Journal of Infectious Diseases. 150: 752-60. PMID 6387001 DOI: 10.1093/Infdis/150.5.752  0.353
1983 Brovall C, Levitz SM, Ellner JJ, Schacter B. Radioresistance of culture-induced augmented natural killer-like activity. Human Immunology. 7: 151-62. PMID 6192119 DOI: 10.1016/S0198-8859(83)80003-2  0.329
Show low-probability matches.